Effects of avitinib on the pharmacokinetics of osimertinib in vitro and in vivo in rats.
Qingjun WuHui JiangShuanghu WangDapeng DaiFeifei ChenDeru MengPeiwu GengHongfeng TongYunfang ZhouDebiao PanQuan ZhouChunjie WangPublished in: Thoracic cancer (2020)
For the first time, we systematically investigated the effect of avitinib, one newly developed third-generation EGFR-TKI, on the pharmacokinetics of osimertinib both in vitro and in vivo using a rat model.